Profitelligence Profitelligence · Filing Ledger Open HOLX research →

Form 8-K · Current Report · Filed 2024-01-08

Hologic Reports Preliminary Q1 Revenue of $1.013B, Exceeding Guidance

Hologic, Inc. announced preliminary revenue results for Q1 2024 on January 7, 2024, reporting $1,013.1 million, which exceeded the guidance range of $960 to $985 million. Organic revenue excluding COVID-19 grew by 5.2%, also surpassing guidance. The company is expected to report non-GAAP diluted EPS towards the high end of the $0.92 to $0.97 guidance range. Full financial results are scheduled for release on February 1, 2024.

Filer
Hologic Inc. HOLX · NASDAQ
Filed
Accession
0001157523-24-000028
CIK
0000859737
Signal
Medium impactHealthcare

Items reported

Item 2.02

Results of Operations and Financial Condition

Earnings Beat General Statement
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$72.95

Next session

-1.1%

Since filing

+4.2%

Latest close

$76.01

What happened, not what will happen — closing prices around the filing date.

Exhibits (1)

About Hologic Inc.

Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.

Exchange NASDAQ Industry Medical Instruments & Supplies Company website ↗

Never miss another HOLX filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts